
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+8
Receptor.AI is a next-generation TechBio company revolutionizing drug discovery with a multiplatform AI-powered ecosystem. We specialize in designing small molecules, peptides, and drug conjugates, accelerating the development of novel therapies for challenging targets. Our ecosystem features dedicated platforms for Induced Proximity, Drug Conjugates, and Monofunctional Compounds built on rigorous validation. These platforms are based on technologies such as leading AI-docking model ArtiDock, proprietary PPI prediction AI model surpassing AlphaFold-Multimer, and dozens of experimentally validated AI models tailored for specific cases in drug design. With a portfolio of >40 projects and an overall success rate of 85%, Receptor.AI is making a...
Artificial intelligence,drug discovery,deep learning,reinforcement learning,drug repurposing,medicinal chemistry,qsar,lead optimisation,drug form & solubility,target identification,nlp,chemoinformatics,and bioinformatics
Receptor.ai operates in the Biotechnology research industry.
Receptor.ai's revenue is 11m - 100m
Receptor.ai has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.